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Introduction

The granulomatous inflammatory response is ubiquitous in pathology, being a manifestation of many infective, toxic, allergic, autoimmune and neoplastic diseases and also conditions of unknown etiology. Granulomatous diseases and reactions are a regular occurrence in everyday clinical histopathology (1). Granulomas are structured masses composed of lymphocytes and macrophage-derived cells, which assume an epithelioid aspect. They may occur in any tissue or organ (2). The granulomas in tuberculosis, extrinsic allergic alveolitis (hypersensitivity pneumonitis), and chronic beryllium disease are often identical to those of sarcoidosis, and historically have been called "classical sarcoid granulomas" (3). Observations that granulomas are of differing morphology led to numerous attempts to classify granulomatous inflammation, either to help in the diagnosis of granulomatous dis-ease or to further the understanding of the granulomatous process. Granulomas have been divided into "foreign body"
and "epithelioid", "low turnover" and "high turnover", "immunological type" and "non-immunological type". However, no classification has been very successful (1) .
Pathologists usually differentiate granulomatoses by their morphologic appearance into epithelioid cell granulomas with necrosis and non-necrotizing granulomas. The distribution pattern of the lung granulomas may assist in sorting out specific diseases. However, the distribution pattern may not be assessed in bronchoscopic lung biopsies (4) .
Usually biopsy data are a basis for clinical diagnosis and direct therapy method. The aim of this study was to evaluate the diagnostic value of the epithelioid cell granulomas in the bronchoscopic bronchial and lung biopsies in a daily clinical practice. 
Materials and Methods
Discussion
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Final clinical diagnosis n % next largest group after sarcoidosis in our study population. (15) 
Lithuania is a moderate tuberculosis-burden country. The incidence of lung tuberculosis in Lithuania is about 50 cases per 100,000 population (11). These facts may influence our results significantly. In tuberculosis, histologically the sites of active involvement are marked by a characteristic granulomatous inflammatory reaction that forms both caseating and noncaseating tubercles (12). The basic histopathological lesion in sarcoidosis is the noncaseating epithelioid cell granuloma (13). But noncaseating epithelioid cell granuloma was found in 24% of our patients with tuberculosis. Recently Ergete and Bekele (14) demonstrated that the frequency of epithelioid cell granuloma without necrosis in Ethiopian patients with tuberculosis is 3.4%. Fenhalls et al
related to the different health status of our patients as well as various stages of the disease (as necrosis is the next step after the granuloma formation). For clinical practice it means that even in cases of advanced tuberculosis in bronchoscopic biopsy (when much more limited amount of material is available) only nonnecrotic granulomas may be found. Surely clinical diagnosis is based not only on biopsy data, but in daily clinical practice in a significant number of cases it is difficult to distinguish Stages II and III sarcoidosis from focal non-destructive tuberculosis. Protective immunity is characterized by the formation of granulomas at the site of infection (16). Clinical experience indicates that host immunity plays an important role in the host-pathogen interaction occurring in persons exposed to Mycobacterium tuberculosis. There is compelling clinical evidence that, in addition to the innate virulence of the M. tuberculosis itself, the host response plays a major role in determining the clinical manifestations and ultimate outcome of persons who encounter this pathogen (17). We thought that we investigated our patients rather soon after the onset of the active tuberculosis. The explanation for this phenomenon could be simple; a great part of the population of Lithuania undergoes an annual chest X-ray or once in two years.
In our study, 4% of our non-necrotizing epithelioid cell granuloma cases were related to carcinoma of the lung and 3% cases were related to other malignant diseases. These results are in line with those described by others authors (18) (19) (20) (26) . If diagnosis requires pulmonary tissue, multiple lung segments may need to be sampled to achieve at least 85% of diagnostic yield of transbronchial biopsy for sarcoidosis (27) 
